Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,785 | 43,049 | 65,466 | 112,346 | 4,322 |
| Marketable Securities | 35,711 | 24,688 | 17,381 | N/A | N/A |
| Receivables | 10,509 | 17,377 | 8,299 | 1,528 | 2,579 |
| Inventories | 1,970 | N/A | N/A | N/A | N/A |
| TOTAL | $86,027 | $86,938 | $92,834 | $115,056 | $8,382 |
| Non-Current Assets | |||||
| PPE Net | 356 | 736 | 794 | 884 | 1,039 |
| Investments And Advances | 6,010 | 0 | 20,000 | 15,422 | 0 |
| Intangibles | 73,694 | 73,928 | 0 | 0 | 0 |
| Other Non-Current Assets | 12,040 | 10,725 | 1,712 | 1,579 | 1,788 |
| TOTAL | $92,100 | $85,389 | $22,506 | $17,885 | $2,827 |
| Total Assets | $178,127 | $172,327 | $115,340 | $132,941 | $11,209 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 37,700 | N/A | N/A | 390 |
| Accounts payable and accrued liabilities | 25,456 | 28,403 | 6,169 | 3,038 | 6,647 |
| Other current liabilities | 8,189 | 7,074 | 5,374 | 836 | 172 |
| TOTAL | $34,065 | $73,720 | $12,023 | $4,230 | $7,536 |
| Non-Current Liabilities | |||||
| Long Term Debt | 59,504 | 5,066 | 12,800 | N/A | 391 |
| Other Non-Current Liabilities | 44,892 | 31,677 | 15,397 | 1,593 | 69,694 |
| TOTAL | $104,396 | $36,743 | $28,197 | $1,593 | $70,085 |
| Total Liabilities | $138,461 | $110,463 | $40,220 | $5,823 | $77,621 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,116 | 43,426 | 34,540 | 34,423 | 28,376 |
| Common Shares | 5 | 4 | 3 | 4 | 0 |
| Retained earnings | -505,289 | -399,778 | -353,729 | -267,029 | -258,474 |
| Other shareholders' equity | 648 | -26 | 577 | 186 | 0 |
| TOTAL | $39,666 | $61,864 | $75,120 | $127,118 | $-66,412 |
| Total Liabilities And Equity | $178,127 | $172,327 | $115,340 | $132,941 | $11,209 |